These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 12548214)

  • 41. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis.
    Masuyama H; Suwaki N; Nakatsukasa H; Masumoto A; Tateishi Y; Hiramatrsu Y
    Am J Obstet Gynecol; 2006 Feb; 194(2):551-6. PubMed ID: 16458660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
    Bakalis S; Peeva G; Gonzalez R; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Oct; 46(4):446-51. PubMed ID: 25826154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of small-for-gestational-age neonates: screening by placental growth factor and soluble fms-like tyrosine kinase-1 at 35-37 weeks.
    Fadigas C; Peeva G; Mendez O; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Aug; 46(2):191-7. PubMed ID: 25825848
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maternal serum placental growth factor isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeks' gestation in late-onset pre-eclampsia and small for gestational age neonates.
    Nucci M; Poon LC; Demirdjian G; Darbouret B; Nicolaides KH
    Fetal Diagn Ther; 2014; 35(4):249-57. PubMed ID: 24642536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation.
    Savvidou MD; Noori M; Anderson JM; Hingorani AD; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Dec; 32(7):871-6. PubMed ID: 18814185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2.
    Gotsch F; Romero R; Kusanovic JP; Chaiworapongsa T; Dombrowski M; Erez O; Than NG; Mazaki-Tovi S; Mittal P; Espinoza J; Hassan SS
    J Matern Fetal Neonatal Med; 2008 Jun; 21(6):389-402. PubMed ID: 18570117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation.
    Ohkuchi A; Hirashima C; Takahashi K; Suzuki H; Matsubara S; Suzuki M
    Hypertens Res; 2013 Dec; 36(12):1073-80. PubMed ID: 23966056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.
    Kumazaki K; Nakayama M; Suehara N; Wada Y
    Hum Pathol; 2002 Nov; 33(11):1069-77. PubMed ID: 12454810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
    Ahmad S; Ahmed A
    Circ Res; 2004 Oct; 95(9):884-91. PubMed ID: 15472115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
    Thadhani R; Mutter WP; Wolf M; Levine RJ; Taylor RN; Sukhatme VP; Ecker J; Karumanchi SA
    J Clin Endocrinol Metab; 2004 Feb; 89(2):770-5. PubMed ID: 14764795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation.
    Poon LC; Zaragoza E; Akolekar R; Anagnostopoulos E; Nicolaides KH
    Prenat Diagn; 2008 Dec; 28(12):1110-5. PubMed ID: 19003787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Placental system A amino acid transport is reduced in pregnancies with small for gestational age (SGA) infants but not in preeclampsia with SGA infants.
    Shibata E; Hubel CA; Powers RW; von Versen-Hoeynck F; Gammill H; Rajakumar A; Roberts JM
    Placenta; 2008 Oct; 29(10):879-82. PubMed ID: 18718657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study.
    Keikkala E; Koskinen S; Vuorela P; Laivuori H; Romppanen J; Heinonen S; Stenman UH
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):378. PubMed ID: 27887594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia.
    Koga K; Osuga Y; Yoshino O; Hirota Y; Ruimeng X; Hirata T; Takeda S; Yano T; Tsutsumi O; Taketani Y
    J Clin Endocrinol Metab; 2003 May; 88(5):2348-51. PubMed ID: 12727995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishing reference values for both total soluble Fms-like tyrosine kinase 1 and free placental growth factor in pregnant women.
    Hirashima C; Ohkuchi A; Arai F; Takahashi K; Suzuki H; Watanabe T; Kario K; Matsubara S; Suzuki M
    Hypertens Res; 2005 Sep; 28(9):727-32. PubMed ID: 16419645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin.
    Bujold E; Romero R; Chaiworapongsa T; Kim YM; Kim GJ; Kim MR; Espinoza J; Gonçalves LF; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jul; 18(1):9-16. PubMed ID: 16105786
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determinants of placental vascularity.
    Torry DS; Hinrichs M; Torry RJ
    Am J Reprod Immunol; 2004 Apr; 51(4):257-68. PubMed ID: 15212678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered methylation and expression patterns of genes regulating placental angiogenesis in preterm pregnancy.
    Sundrani DP; Reddy US; Chavan-Gautam PM; Mehendale SS; Chandak GR; Joshi SR
    Reprod Sci; 2014 Dec; 21(12):1508-17. PubMed ID: 24803508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.